Investors Research Corp - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 66 filers reported holding VYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
Investors Research Corp ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$231500.0%0.00%
Q3 2022$01500.0%0.00%
Q2 2022$01500.0%0.00%
Q1 2022$01500.0%0.00%
Q4 2021$01500.0%0.00%
Q3 2021$0150
+200.0%
0.00%
Q2 2021$0500.0%0.00%
Q1 2021$0500.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,551,000$2,602,0002.01%
Perceptive Advisors 4,356,044$4,444,0000.03%
GSA CAPITAL PARTNERS LLP 217,747$222,0000.03%
Virtu Financial LLC 175,278$179,0000.02%
XTX Topco Ltd 17,053$17,0000.01%
SkyOak Wealth, LLC 27,200$28,0000.01%
DELTEC ASSET MANAGEMENT LLC 30,000$31,0000.01%
Tekla Capital Management LLC 135,395$138,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$64,0000.00%
TWO SIGMA SECURITIES, LLC 47,475$48,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders